Viewing Study NCT06402266



Ignite Creation Date: 2024-05-11 @ 8:30 AM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06402266
Status: COMPLETED
Last Update Posted: 2024-05-07
First Post: 2024-02-29

Brief Title: Simultaneous tDCS and Computerised Gamified Short-term Memory Task Feasibility
Sponsor: University of Aarhus
Organization: University of Aarhus

Study Overview

Official Title: Effects of Transcranial Direct Current Brain Stimulation on Apolipoprotein-ε4 Allele Gene Carriers on an App-based Short-term Memory Task
Status: COMPLETED
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ACTTDCS-FG
Brief Summary: The goal of this observational study is to gain insight into the effects of transcranial direct current stimulation tDCS on short-term memory task performance and the feasibility of tDCS in overtly healthy carriers of the susceptibility allele Apolipoprotein APOE ε4 for late-onset Alzheimers disease

The main questions the study aims to answer are

If tDCS is feasible in overtly healthy APOE ε4 carriers using a headset and an app-based short-term memory task
If overtly healthy APOE ε4 carriers perform better on a complex short-term memory task when receiving tDCS to the right hemisphere F4 à PZ compared to the left hemisphere F3 à PZ or sham tDCS

Participants will be asked to complete an app-based short-term memory task while receiving either tDCS to either the right or left hemisphere or sham stimulation on 3 different days spread out over 1-3 weeks
Detailed Description: Alzheimers disease AD is the most common neurodegenerative disorder causing dementia The most common form of AD is that of idiopathic AD or late-onset AD which typically affects individuals above the age of 65 Individuals who are carriers of the Apolipoprotein APOE ε4 allele have an increased risk of developing late-onset AD and AD brain pathology has been observed in APOE ε4 carriers as young as 55 years of age

AD can be perceived as a continuum with the pathophysiological disease process beginning in the brain many years prior to the onset of overt symptoms Thus individuals may show evidence of AD biomarkers in blood or cerebrospinal fluid or on brain scans in the absence of any overt symptoms Individuals with incipient AD brain pathology but no overt symptoms may be classified as preclinical AD APOE ε4 allele carriage increases the risk of developing AD brain pathology 2-4 fold

One of the most common cognitive symptoms in AD is memory impairment such as impairments in short-term memory STM Subtle impairments in memory including in STM can even be detected in preclinical AD using sensitive memory tests Therefore STM may provide a suitable target to help preserve individuals cognitive functioning earlier in the disease process

Cognitive reserve is a hypothetical construct proposed to explain the incongruency between the burden of AD pathology and cognitive dysfunction observed in some older individuals and has been defined as the ability to optimise or maximise performance through differential recruitment of brain networks Epidemiological studies suggest that the cognitive reserve is increased by lifetime exposures including educational and occupational attainment as well as leisure activities in late life An underlying assumption is that these exposures improve brain plasticity Cognitive training has shown positive effects with regards to promoting brain plasticity in older adults and could thus have the potential to foster or strengthen cognitive reserve in individuals at risk for developing AD later in life

Cognitive training in combination with other neuroplasticity-enhancing techniques has been suggested as an option for promoting the positive effects of cognitive training alone Transcranial direct current stimulation tDCS is a noninvasive neuro-modulatory technique where low intensity direct current is delivered to cortical areas to facilitate or inhibit ongoing spontaneous neuronal activity As tDCS has been shown to improve STM in healthy elderly participants combining cognitive training with tDCS may be a way to enhance the effects of cognitive training and enhance cognitive reserve Thus it is sensible to explore the feasibility of tDCS on improving STM during a computerised game targeting STM starting with healthy elderly APOE ε4 allele carriers ie healthy elderly individuals who are genetically predispositioned to AD but who are otherwise healthy

This study aims to investigate the effect of tDCS on memory performance on an app-based STM task in healthy elderly APOE ε4 carriers aged 55-75 All participants will be recruited from an existing in-house registry of individuals who have already been confirmed to be APOE ε4 carriers on a blood test The tDCS or sham stimulation will be delivered by a headseat where the spatial arrangement of the electrodes that delivers the stimulation and their outlets used in the stimulation determines the regions and distributed networks of the brain being stimulated Participants will first try out the app-based STM task on its own in order to become familiar with it Thereafter they will come in on 3 different days within 1-3 weeks where they will complete the same STM task again while undergoing either active or sham tDCS This will allow for the examination of whether active tDCS can improve memory performance on this type of complex STM task in overall healthy elderly individuals who are genetically predisposed for late-onset AD

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None